Percutaneous bioprosthetic venous valve: A long-term study in sheep  by Pavcnik, Dusan et al.
PRELIMINARY INVESTIGATION 
Percutaneous 
term study in 
bioprosthetic 
sheep 
venous valve: Along- 
Dusan Pavcnik, MD, Phi), a Barry T. Uchida, BS, a Hans A. Timmermans, BFA, a Christopher L. Corless, 
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Keller, MD, a and Josef R6sch, MD, a Portland, Ore 
A long-term evaluation of a new percutaneously p aced bioprosthetic, bicuspid venous valve (BVV) consisting of a 
square stent and small intestinal submucosa (SIS) covering was performed in 12 sheep. Of 26 BVVs placed into the 
jugular veins, 25 exhibited good valve function on immediate venography and 22 on venograms obtained before the 
sheep were killed. Gross and histologic examination results demonstrated incorporation fremodeled and endothelial- 
ized SIS BVVs into the vein wall. Slight to moderate leaflet hickening was found mostly at their bases. Percutaneously 
placed SIS BVV is a promising one-way, competent valve that resists venous back-pressure while allowing forward flow. 
(J Vase Surg 2002;35:598-602.) 
Several attempts have been made to develop a percu- 
taneously placed prosthetic or bioprosthetic venous valve 
(BVV)3 -4 Although these valves exhibited partial short- 
term success, they were not evaluated on a long-term 
basis. 
We present a long-term experimental study of a new per- 
cutaneously placed square stent-based BVV.5, 6 We tested it 
in sheep jugular veins fbr deployment, long-term function, 
competency, patency, stability, and biocompatibility. 
METHODS 
The study involved 12 adult female sheep weighing 
67.7 to 85.5 kg (mean 72.3 kg). The Institutional Animal 
Care and Use Committee of the Oregon Health Sciences 
University approved the study. 
BVV. The BVVs were constructed of square stents 
(0.0075-inch stainless teel wire) with four barbs (Cook 
Inc, Bloomington, Ind) and a sheet of small intestinal sub- 
mucosa (SIS) (Cook Biotech, Lafayette, Ind). 5-7 Two 
pieces of SIS were sutured with 7.0 Prolene monofilament 
to the stent frame to fbrm the BVV (Fig 1). BVVs were 
constructed in three sizes (11 rnm, 13 ram, and 15 mm in 
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diameter). Of 26 BVVs used for testing, 14 were hydrated, 
and 12 were lyophilized. 
Animal experiment. The external jugular vein (EJV) 
in sheep was chosen fbr study because of its similar size to 
human femoral vein. An 11F polytetrafluoroethylene 
sheath was introduced percutaneously into each EJV. 
After administration of heparin 6000 IU, jugular 
venograms were obtained. Diameters of both EJV were 
measured, and BVVs with approximately the same diam- 
eters as the EJV were selected for implantation. Hydrated 
BVV was connected to the retention wire (Cook Inc) and 
preloaded at the end of a 9F 40-cm-long polytetrafluo- 
roethylene sheath. Lyophilized BVV was preloaded and 
rehydrated with injection of saline solution 10 mL 15 
minutes before delivery. 5,6 
Eleven sheep received one BVV into the distal EJV 
bilaterally. Three animals received one additional BW in 
their common jugular vein (CJV). Twelve BVVs were 
placed centrally (closer to the heart), 1 1 across and two dis- 
tal to the native valves (NV). The BVV delivery was accom- 
plished by withdrawal of the sheath while the retention 
wire was held. As the BVV was deployed, it self-expanded 
and self-attached to the vein wall. It was then released from 
the locking retention wire. Immediate function and stabil- 
ity of BVVs were studied by venograms obtained with a 6F 
catheter positioned centrally and distally to the deployed 
BVVs. Antibiotics (oxytetracycline 10 mg/kg/d),  but no 
additional anticoagulation drugs, were given for 3 days. 
FoUow-up, Before the sheep were killed, patency of 
the BWs was studied with indirect venography by con- 
trast injection into the common carotid artery. Direct 
venography, both central and peripheral to the valve, was 
also done as described above. Two animals were killed at 
1 month and five at 3 and 6 months. 
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Fig 1. Bicuspid venous valve (BVV) 14 to 15 mm in diameter. A, Nonrestricted BVV 20 mm long with tbur 
barbs retained by retention wire pusher connected t  one barb. B, BVV front-loaded into 9F guiding 
catheter. C, BVV detached from retention wire. 
Fig 2. Function of BWs placed into both EJVs immediately after placement. A, Jugular venogram with 
injection distal o valve demonstrates valve p tency. This is analogous to animal standing upright. B, High-
volume injection central to valve demonstrates closure f valve with no leak. Valves must thnction in this 
manner to prevent cephalic reflux when animal lowers its head to eat or drink. 
Gross and histologic studies. Gross examination 
focused on the EJV, CJV, surrounding structures, and 
lungs. Veins with the BW were photographed, har- 
vested, and preserved in formalin. Specimens were cut 
longitudinally to expose lumen, and the BW was pho- 
tographed. The wires of the BW were then removed, 
and the specimens were further processed and embed- 
ded in paraffin. Paraffin sections 5 gm in length were cut 
and stained with hematoxylin and eosin or Masson's 
trichrome stain. 
RESULTS 
EJV diameters and angiographic results of BW place- 
ment are summarized in the Table (online only). The EJV 
diameter ranged from 9.7 mm to I5.0 mm (mean 12.0 _+ 
1.4 ram), and CJV ranged from 14.7 mm to 15.6 mm 
(mean 15.2 _+ 0.4 mm), respectively. Placement of 25 
BVVs was successful. One BW failed to open properly 
and migrated into the distal right pulmonary artery with 
no adverse sequelae. It was immediately replaced with a 
new valve. Good self-expansion and centering of both 
BWs leaflets was seen in 22 vessels (88%). In three ani- 
mals BW expansion in one of the EJVs was uneven 
because of tilting of the valve (12%). Postplacement 
venograms obtained distal to the BWs showed unim- 
paired blood flow through all BWs (100%). Vcnograms 
obtained central to the BW showed no reflux in 24 valves 
(96%; Fig 2). Moderate reflux of contrast medium was 
seen in one tilted valve (4%). 
Studies performed betbre the sheep were killed showed 
no BW migration. Twenty-two valves (88%) functioned 
well on venography with no leak. Of the three tilted valves, 
one was thrombosed at 1 month (4%). Two other tilted 
valves (8%) were patent at 3 months with moderate reflux. 
Gross and histologic examination. All BWs were 
securely anchored against he EJV or CJV wall. Barb pen- 
etration through the vein wall was seen in 14 vessels 
(56%). The animal with the thrombosed BW had moder- 
ate perivenous inflammation (4%), otherwise no reaction 
or damage to the surrounding structures was found. 
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Fig 3. Lyophilized BVV placed across native valve in animal 2 at 1 month. A, Jugular vein 
specimen shows smooth incorporation f BVV into vein wall. B, BW cusp consists of free bor 
der remodeled SIS and normal vein wall. C, Longitudinal microscopic view of one SIS leaflet. 
D, Magnified view of remodeled SIS leaflet reveals host ti sue replacement and collagenous 
stroma remodeling with fibrocytes, plasma cells, and lymphocytes. Vascular endothelial cel s 
(arrow) cover leaflet. (Hematoxylin & eosin stain; original magnification × 400.) 
Longitudinal dissection demonstrated smooth incorpora- 
tion of the BVV into the vein wall. Glistening leaflet sur- 
faces were seen in 24 veins (96%; Fig 3). 
At the BVV agger the SIS membranes were thickened 
from approximately 600 to 4000 ~m (mean 1485 _+ 623). 
The length of this thickened area ranged from 0.7 mm to 
6.9 mm (mean 3.9 + 2.1 mm) measured from the valve 
base. Microscopic examination showed that all BVVs con- 
sisted of remodeled collagen, with islands of unorganized 
SIS material at the valve base. SIS leaflets were fully pene- 
trated by fibrocytes, lymphocytes, plasma cells, and histio- 
cytes. There was complete ndothelization of the BVV 
leaflets on both sides. Ncovascularization was evident by 
the presence of capillaries within the matrix of fibroblasts 
(Fig 4). These findings were similar at 1, 3, and 6 months' 
fbllow-up. Animal 8, killed at 6 months, showed dys- 
trophic calcifications within the partially remodeled 
hydrated SIS material of one thickened leaflet. 
DISCUSSION 
A manufactured, percutancously implantable, non- 
imunogenic venous valve that remains patent and competent 
over time is an attractive alternative todirect venous valvular 
reconstruction r transplantation. The combination of a 
square stent and the biomaterial SIS 8,9 permits manuthcture 
ofa BVV that is anatomically and functionally similar to NV. 
Attached to a square stent, SIS provides an effective bioscaf- 
fold for attraction of host cells. The BVV incorporated into 
a vein wall consists of two cusps, the valvular agger and the 
valvular sinus. The cusp consists of a free border (SIS) and 
parietal part (vein wall). The lyophilized and hydrated SIS 
used in these experiments were 120 pm and 180 btm thick, 
respectively, and were approximately 4 and 6 times thicker 
than natural valve (30 btm). 
At the BW agger, where the SIS leaflets were 
attached to he vein wall, the SIS membranes were thick- 
ened. This chronic inflammation and cellular ingrowth 
around sutures and the stent wires created a seal between 
the vein wall and the two valve pockets. Parietal borders of 
BW sinuses consisted of natural vein wall, with intact 
endothelium preventing local thrombosis. Of 25 BW 
with 50 cusps, only one pocket (2%) of a single misaligned 
BW thrombosed. This suggests that the SIS valve is 
resistant to thrombosis. Venous endothelial cells were 
attached to SIS 1 month after implantation. As this 
process continued other cells infiltrated the SIS, and the 
ingrowth of the host cells allowed incorporation of the 
valve and its borders into the vein wall. 
After deployment, the BVVs self-expanded and 
appeared to function in the same manner as a natural 
venous valve. The BVV was open during continuous ante- 
grade flow. When retrograde pressure was applied, the 
BVVs closed, and the two SIS leaflets sealed against each 
other, thus preventing retrograde flow through the valve. 
BWs placed into jugular veins centrally (closer to heart) 
or across the NV took over the function of these valves. All 
11 BVVs placed across the NVs were functional with min- 
imally thickened leaflets (mean 253 ± 114 ~tm) after 1, 3, 
and 6 months. Twelve BWs placed centrally to the NV 
had leaflets thickened to a mean of 744 e 481 ~m. This 
suggests that when replacing the function of the natural 
valve in their location, BVVs have the best chance to func- 
tion and not thicken. Dystrophic alcifications were found 
in only one thickened leaflet (1760 btm) at 6 months (2%), 
perhaps indicating that the SIS valve has less tendency to 
calci~ than glutaraldehyde-treated xenograft valves. 1° We 
did not find significant differences between hydrated and 
lyophilized SIS in remodeling or leaflet hickness at 1, 3, 
and 6 months. 
The BVVs described herein demonstrate several 
advantages over other prosthetic venous valves. 1-4 These 
include simple introduction with valve self:expansion a d 
self-attachment by barbs to the vein wall. The valve 
appears table and does not spontaneously migrate. The 
size of the delivery catheter for BVV is similar to that for 
delivery of a monocusp valve. 1 It is, however, much 
smaller than the 16F size for the bicuspid SIS covered Z 
stcnt valve 4 and the 18F size required for insertion of a 
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Fig 4. Hydrated BVV at 6 months in animal 9. A, Jugular venogram injection distal to BVV demonstrates vane patency. B, Venogram 
with injection central to valve demonstrates closure of BVV with no reflux. C, Exposed vein is slightly distended by pressure of square 
stent wires with no reaction or damage to surrounding structures. D~ Longitudinal microscopic view of both SIS leaflets. E, Magnified 
view of remodeled SIS leaflet shows endothelial cells covering valve leaflet with fibrous tissue, fibrocytes, and some inflammatory cells. 
There is evidence of neovascularization (arrows). (Hematoxylin & eosin stain; original magnification x 400.) 
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s tent -mounted  bovine jugu lar  vein valve. 2,3,5 Another  
advantage o f  the BVVs is their availability in different sizes 
for various vein diameters. They may also not  require anti- 
coagulation. The  results o f  this study are encouraging and 
warrant  an experimental trial in human beings. 
We thank Martina Basin Pavcnik, Sheri Imai-Swiggart, 
Andy Hoffa, Joe Obermiller, and Ray Leonard for their 
assistance. 
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